Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2023: 3.04%

Shanghai Haoyuan Chemexpress Co., Ltd. Return on Assets (ROA) is 3.04% for the year ending December 31, 2023, a -43.52% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • Shanghai Haoyuan Chemexpress Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2022 was 5.38%, a -32.80% change year over year.
  • Shanghai Haoyuan Chemexpress Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2021 was 8.01%, a -46.57% change year over year.
  • Shanghai Haoyuan Chemexpress Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2020 was 14.99%, a 10.74% change year over year.
  • Shanghai Haoyuan Chemexpress Co., Ltd. Return on Assets (ROA) for the year ending December 31, 2019 was 13.54%, a 123.81% change year over year.
Key data
Date Return on Assets (ROA) Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio
Market news
Loading...
SV Wall Street
Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO Mr. Baofu Zheng
IPO Date June 8, 2021
Location China
Headquarters No. 3 Building, No. 1999
Employees 3,370
Sector Health Care
Industries
Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Similar companies

688188.SS

Shanghai Friendess Electronic Technology Corporation Limited

USD 27.46

0.92%

688289.SS

Sansure Biotech Inc.

USD 2.78

-1.27%

300725.SZ

PharmaBlock Sciences (Nanjing), Inc.

USD 4.31

-0.79%

688301.SS

iRay Technology Company Limited

USD 14.05

-1.15%

StockViz Staff

February 1, 2025

Any question? Send us an email